Atlas Trials

EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer

Clinical trial NCT04465500 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04465500
Sponsor
University of Virginia
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate CancerProstate Adenocarcinoma
Start date
2025-01-30
Primary completion
2028-01-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.